Faecal Microbiota Transplantation in Inflammatory Bowel Disease: Current Concepts and Future Challenges.

Abstract:

:Dysbiosis has been repeatedly observed in inflammatory bowel disease (IBD) and is now recognized as an essential factor in the gut inflammatory process. IBD is a significant burden to health-care systems, mainly due to treatment-related costs. Available treatments have several limitations: up to 30% of patients are primary non-responders, and between 10 and 20% lose response per year, requiring a dose-escalation or a switch to another biologic. Hence, the current IBD treatment is not sufficient, and there is an urgent need to introduce new therapies in the management of these patients. Recently, the correction of dysbiosis has become an attractive approach from a therapeutic point of view. Faecal microbiota transplantation (FMT) appears as a reliable and potentially beneficial therapy in IBD patients. There is developing data that FMT for mild-to-moderately active UC is a safe and efficient therapy for the induction of remission. However, the current studies have different designs and have a short follow up, which makes clinical interpretation significantly difficult. There is a need for RCTs with a well-defined study cohort using FMT for the therapy of CD patients. The location, behavior, and severity of the disease should be taken into account. The goal of this manuscript is to review the data currently available on FMT and IBD, to explain FMT principles and methodology in IBD patients and to discuss some unresolved issues.

journal_name

Curr Drug Targets

journal_title

Current drug targets

authors

Zatorski H,Nakov R

doi

10.2174/1389450121666200602125507

subject

Has Abstract

pub_date

2020-01-01 00:00:00

pages

1440-1447

issue

14

eissn

1389-4501

issn

1873-5592

pii

CDT-EPUB-107038

journal_volume

21

pub_type

杂志文章
  • Clinical aspects of natural anti-angiogenic drugs.

    abstract::Natural products represent a rich resource for drug delivery and are currently being exploited to target tumour angiogenesis. A vast array of products of natural origin have been shown to have anti-angiogenic potential in preclinical models, including purified endogenous inhibitors, and exogenous compounds derived fro...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006776054951

    authors: Neal CP,Berry DP,Doucas H,Manson MM,Steward W,Garcea G

    更新日期:2006-03-01 00:00:00

  • Expression and functions of galectin-1 in sensory and motoneurons.

    abstract::Galectin-1 (Gal1) was the first identified member of the galectin family of beta-galactosidase-binding proteins. Gal1 has important roles in processes fundamental to growth and survival of an organism, including cell adhesion, cell proliferation and apoptosis, and is expressed in many tissues, including the nervous sy...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450054021864

    authors: Gaudet AD,Steeves JD,Tetzlaff W,Ramer MS

    更新日期:2005-06-01 00:00:00

  • Is Galanin a Promising Therapeutic Resource for Neural and Nonneural Diseases?

    abstract:BACKGROUND:Galanin (GAL) constitutes a family of neuropeptides composed of four peptides: (i) galanin (GAL), (ii) galanin-message associated peptide (GAMP), (iii) galanin-like peptide (GALP), and (iv) alarin. GAL contains 29/30 amino acids, and its biological action occurs through the interactions with its various rece...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200225112055

    authors: Oliveira Volpe CM,Vaz T,Rocha-Silva F,Villar-Delfino PH,Nogueira-Machado JA

    更新日期:2020-01-01 00:00:00

  • Urinary Bone Turnover Markers as Target Indicators for Monitoring Bisphosphonate Drug Treatment in the Management of Osteoporosis.

    abstract:BACKGROUND:Osteoporosis is a debilitating disease characterized by bone micro-architecture degradation contributing to fragility fractures. Currently, determining bone mineral density (BMD) via dual-energy X-ray absorptiometry (DXA) is the most reliable form of diagnosing osteoporosis and managing pharmacological treat...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450118666170704143529

    authors: Kwon S,Wang AH,Sadowski CA,Yuksel N,Doschak MR

    更新日期:2018-01-01 00:00:00

  • Metal and inflammatory targets for Alzheimer's disease.

    abstract::Alzheimer's disease (AD) has become linked to inflammation and metal biology. Metals (copper, zinc and iron) and inflammatory cytokines are significant factors that increase the onset of sporadic late onset forms of the dementia. The genetic discovery that alleles in the hemochromatosis gene accelerate the onset of di...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450043345272

    authors: Rogers JT,Lahiri DK

    更新日期:2004-08-01 00:00:00

  • Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.

    abstract::Circulating tumor cells (CTCs) have attracted interest as biomarkers of cancer metastases but only recently has a reliable method of CTC detection been developed. CTCs can be thought of as a liquid biopsy from the blood, and they can be used in pathological and molecular assays. CTCs may ideally replace metastatic tis...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:

    authors: Cai LL,Ye HM,Zheng LM,Ruan RS,Tzeng CM

    更新日期:2014-01-01 00:00:00

  • Triplex-forming oligonucleotides - sequence-specific DNA ligands as tools for gene inhibition and for modulation of DNA-associated functions.

    abstract::The down regulation of gene expression is a promising strategy for molecular medicine and experimental biology. Molecules that bind to the DNA double helix may interfere with gene expression and, in addition to potential therapeutic applications, can be helpful for the investigation of DNA processing, chromatin packag...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450043345100

    authors: Besch R,Giovannangeli C,Degitz K

    更新日期:2004-11-01 00:00:00

  • Potential options to treat hypertriglyceridaemia.

    abstract::Hypertriglyceridaemia is associated with insulin resistance, hypertension, obesity and diabetes. The management of hypertriglyceridaemia and atherogenic dyslipidaemias increasingly involves the use of several drugs for different aspects of the metabolic syndrome. This review highlights the agents for treatment of bloo...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945009787846380

    authors: Viljoen A,Wierzbicki AS

    更新日期:2009-04-01 00:00:00

  • A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin.

    abstract:BACKGROUND:The plant milk thistle and silymarin has been traditionally used as a natural remedy for the treatment of various ailments including neurological disorders such as Alzheimer's and Parkinson's disease and cerebral ischemia for over 2000 years. OBJECTIVE:In this article we review the neuroprotective effects o...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666161227125121

    authors: Devi KP,Malar DS,Braidy N,Nabavi SM,Nabavi SF

    更新日期:2017-01-01 00:00:00

  • Pharmacological treatments for neovascular age-related macular degeneration: can mixed treatment comparison meta-analysis be useful?

    abstract:OBJECTIVE:To investigated the use of mixed treatment comparison (MTC) meta-analysis models to summarize results from randomized clinical trials (RCTs) on approved pharmacological treatments for neovascular age-related macular degeneration (AMD). METHODS:The number of patients with visual loss or visual gain of 3 or mo...

    journal_title:Current drug targets

    pub_type: 杂志文章,meta分析,评审

    doi:10.2174/138945011794182665

    authors: Virgili G,Novielli N,Menchini F,Murro V,Giacomelli G

    更新日期:2011-02-01 00:00:00

  • Tachykinins: role in human gastrointestinal tract physiology and pathology.

    abstract::Tachykinins (TKs) and their receptors (NK1, NK2 and NK3), which are diffusely expressed in the human gastrointestinal tract, represent an endogenous modulator system regulating enteric secretomotor functions, inflammatory and immune responses, and visceral hypersensitivity, mainly during pathological gut diseases. Pat...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006778019354

    authors: Improta G,Broccardo M

    更新日期:2006-08-01 00:00:00

  • TGF-Beta signaling manipulation as potential therapy for IBD.

    abstract::Crohn's disease (CD) and ulcerative colitis (UC), two chronic and relapsing inflammatory bowel diseases (IBD), are supposed to develop in genetically-predisposed individuals as a result of an excessive immune mucosal response directed against normal components of the gut microbiota. There is also evidence that defects...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/13894501113149990157

    authors: Marafini I,Zorzi F,Codazza S,Pallone F,Monteleone G

    更新日期:2013-11-01 00:00:00

  • Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.

    abstract::The use of imatinib, second and third generation ABL tyrosine kinase inhibitors (TKI) (i.e. dasatinib, nilotinib, bosutinib and ponatinib) made CML a clinically manageable and, in a small percentage of cases, a cured disease. TKI therapy also turned CML blastic transformation into a rare event; however, disease progre...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160615074120

    authors: Perrotti D,Silvestri G,Stramucci L,Yu J,Trotta R

    更新日期:2017-01-01 00:00:00

  • Nitrite-stimulated Gastric Formation of S-nitrosothiols As An Antihypertensive Therapeutic Strategy.

    abstract::Hypertension is usually associated with deficient nitric oxide (NO) bioavailability, and therefore stimulating NO activity is an important antihypertensive strategy. Recently, many studies have shown that both nitrite and nitrate anions are not simple products of NO metabolism and indeed may be reduced back to NO. Whi...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450119666180816120816

    authors: Oliveira-Paula GH,Tanus-Santos JE

    更新日期:2019-01-01 00:00:00

  • Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy.

    abstract::Non-small cell lung cancer (NSCLC) represents close to 90% of all lung cancers. When diagnosed, most cases are on an advanced and inoperable stage, with limited therapeutic options. Existing therapies have shown to be insufficient and novel strategies are urgently necessary. New advances in understanding the disease a...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450115666140528151649

    authors: Nascimento AV,Bousbaa H,Ferreira D,Sarmento B

    更新日期:2015-01-01 00:00:00

  • The complex biology of FOXO.

    abstract::FOXO transcription factors control proliferation, apoptosis, differentiation and metabolic processes. Loss of FOXO function has been identified in several human cancers, and results in increased cellular survival and a predisposition to neoplasia, especially in epithelial cancer. FOXO factors are therefore bona fide t...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011796150307

    authors: Monsalve M,Olmos Y

    更新日期:2011-08-01 00:00:00

  • The Role of JNK Signalling in Responses to Oxidative DNA Damage.

    abstract::The production of reactive oxygen species is a normal part of cell physiology, but many internal and external stimuli are able to trigger the production of excess levels of oxidants that are potentially damaging. The threat of oxidative damage is particularly significant to DNA, as damaged bases can interfere with rep...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150126111055

    authors: Shaukat Z,Liu D,Hussain R,Khan M,Gregory SL

    更新日期:2016-01-01 00:00:00

  • Reproductive Toxicity of T Cells in Early Life: Abnormal Immune Development and Postnatal Diseases.

    abstract::Immunity is a balanced status with adequate biological defenses to recognize and fight "non-self", as well as adequate tolerance to recognize "self". To maintain this immune homeostasis, a well-organized T cell immune network is required, which in part depends on the well-controlled development of alternative effector...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666161124145641

    authors: Liu HX,Jiang A,Chen T,Qu W,Yan HY,Ping J

    更新日期:2017-01-01 00:00:00

  • Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia.

    abstract:BACKGROUND:Preeclampsia, a gestational disease characterized by hypertension and proteinuria twenty weeks into pregnancy, is one of the leading causes of fetal and maternal mortality. Although multiple genetic and environmental factors are found to be related to the preeclampsia risk, the pathogenic pathways remain lar...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450118666170404160000

    authors: Song X,Luo X,Gao Q,Wang Y,Gao Q,Long W

    更新日期:2017-01-01 00:00:00

  • Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy.

    abstract::Excessive production of reactive oxygen species is an important mechanism underlying the pathogenesis of diabetes associated macrovascular and microvascular complications including diabetic nephropathy. Diabetic nephropathy is characterized by glomerular enlargement, early albuminuria and progressive glomerulosclerosi...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450115666140321120635

    authors: Arora MK,Singh UK

    更新日期:2014-05-01 00:00:00

  • New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer.

    abstract::The androgen receptor (AR) signalling pathway remains a key driver of prostate cancer progression despite castrate levels of testosterone in advanced disease. The androgen biosynthesis inhibitor abiraterone and the anti-androgen enzalutamide have been shown to prolong survival in randomized clinical trials both pre-an...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150907101044

    authors: Assi R,Temraz S,Shamseddine A,Mukherji D

    更新日期:2016-01-01 00:00:00

  • Patient-controlled analgesia.

    abstract::Using a portable infusion pump, intravenous opioid patient-controlled analgesia (PCA) permits a patient to self-deliver a small bolus of opioid to achieve prompt relief without over sedation. Use of PCA for pain management is increasing in hospitals, largely because it can provide equivalent or better analgesia than c...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945005774574524

    authors: Mann C,Ouro-Bang'na F,Eledjam JJ

    更新日期:2005-11-01 00:00:00

  • Beneficial effects of plant sources on the treatment of osteoporosis.

    abstract::Osteoporosis causes bone loss, and makes bone to susceptible to fracture. The main cause of osteoporosis is estrogen deficiency. Estrogen, calcitonin, calcium, vitamin D and antioxidants can be used to prevent osteoporosis. For the treatment of osteoporosis, the potential biological activities of traditional medicines...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/13894501113149990205

    authors: Süntar I,Akkol EK

    更新日期:2013-12-01 00:00:00

  • The link between Hepatic Vitamin A Metabolism and Nonalcoholic Fatty Liver Disease.

    abstract::The liver is essential for the control of glucose and lipid metabolism. Excessive accumulation of fat in the liver disturbs its function and leads to the development of fatty liver diseases. The nonalcoholic fatty liver disease (NAFLD) is a common type of fatty liver disease found in patients who have not consumed sig...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150325231015

    authors: Chen G

    更新日期:2015-01-01 00:00:00

  • Nanocarrier Based Advances in Drug Delivery to Tumor: An Overview.

    abstract:BACKGROUND:Nanotechnology deals with the manufacturing of materials at the atomic and molecular scale. According to the National Nanotechnology Initiative, nanotechnology denotes those structures which are nearly in 1-100 nm size regime in at least one dimension. OBJECTIVE:Nanotechnology in drug delivery has been evid...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450119666180131105822

    authors: Jain A,Kumari R,Tiwari A,Verma A,Tripathi A,Shrivastava A,Jain SK

    更新日期:2018-01-01 00:00:00

  • Animal models of carcinogenesis in inflamed colorectum: potential use in chemoprevention study.

    abstract::Inflammation is a risk factor for cancer development in several tissues. In the colorectum, inflammatory bowel disease (ulcerative colitis and Crohn's disease) is a longstanding inflammatory disease with increased risk for colorectal cancer (CRC). Several molecular events involving in chronic inflammatory process cont...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012804545452

    authors: Tanaka T

    更新日期:2012-12-01 00:00:00

  • Advancement of Mechanisms of Coxsackie Virus B3-Induced Myocarditis Pathogenesis and the Potential Therapeutic Targets.

    abstract::Viral myocarditis is a cardiac disease caused by Group B Coxsackie virus of Enterovirus genus in the Picorna viridae family. It causes heart failure in children, young and adults. Ten Percent (10%) of acute heart failure and 12% of sudden deaths in young and adults who are less than 40 years is due to this viral myoca...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450120666190618124722

    authors: Daba TM,Zhao Y,Pan Z

    更新日期:2019-01-01 00:00:00

  • Historical observations on the discovery of platelets, platelet function testing and the first antiplatelet agent.

    abstract::An understanding of the historical paths that have lead to our current state of knowledge in the field of platelet studies can be both illuminating and inspiring. Considering that the existence and function of platelets were initially described just barely over 100 years ago it is exciting to recognize how far our kno...

    journal_title:Current drug targets

    pub_type: 历史文章,杂志文章

    doi:10.2174/138945011797635858

    authors: Steinhubl SR

    更新日期:2011-11-01 00:00:00

  • Potential therapeutic targets for neurodegenerative diseases: lessons learned from calorie restriction.

    abstract::It is well known that calorie restriction (CR) can retard the aging process in organisms ranging from yeast to non-human primates, and delay the onset of numerous age-related diseases including neurodegenerative disorders. Translation of the knowledge gained from CR research in animal models to disease prevention stra...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111007011281

    authors: Duan W,Ross CA

    更新日期:2010-10-01 00:00:00

  • Portals and Web-Based Resources for Virtual Screening.

    abstract::Virtual screening for active compounds has become an essential step within the drug development pipeline. The computer based prediction of compound binding modes is one of the most time and cost efficient methods for screening ligand libraries and enrich results of potential drugs. Here we present an overview about cu...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160201105806

    authors: Krüger J,Thiel P,Merelli I,Grunzke R,Gesing S

    更新日期:2016-01-01 00:00:00